News

AddToAny

Google+ Facebook Twitter Twitter

Infectious periods in vaccinated individuals

To examine the infectious periods in vaccinated individuals infected with the SARS-CoV-2 Omicron and Delta variants, US researchers collected daily anterior nasal swabs for at least 10 days from a group of college students and staff for reverse transcription-polymerase chain reaction test and culture and with antigen rapid diagnostic testing (RDT) on a subset of individuals.

They found that in the majority of young, healthy and vaccinated adults, the infectious period for SARS-CoV-2 is limited, with only 17% remaining positive beyond five days.

The researchers compared infection with Omicron versus Delta, vaccination status and the difference from test date and symptom onset date on detectable virus and culture positivity.

They found there was no difference in time to culture conversion by variant or vaccination status. Among participants in the subset who used an antigen RDT in days five through seven following SARS-CoV-2 diagnosis, RDT had perfect negative predictive value and sensitivity when compared to culture.

“We believe that RDT may provide reassurance of lack of infectiousness, though masking for a full 10 days is necessary to prevent transmission from the 17% of individuals who remain culture positive after isolation,” said Tara Bouton, corresponding author.

bit.ly/3bz9ykb

Image credit | iStock

Related Articles

soft tissue sarcoma CREDIT -shutterstock - 2302813459

Sarcoma relapse risk reduced by 43%

A global team of researchers has announced clinical trial results that point to a new immunotherapy treatment option for two of the most common types of soft tissue sarcoma in adults.

nephrotic syndrome you yes CREDIT - shutterstock -639997780

Under the microscope: nephrotic syndrome

This month: Nephrotic syndrome

eProtein Discovery side-CREDIT_Supplied

Tech round up: June 2024

Best new tech this month

Natural-killer cells attacking a cancer cel - CREDIT - Science-Photolibrary-f0339843

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Top